213 related articles for article (PubMed ID: 24574517)
1. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation.
Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J
Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517
[TBL] [Abstract][Full Text] [Related]
2. Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.
Delury C; Hart C; Brown M; Clarke N; Parkin E
Biochem Biophys Res Commun; 2016 Mar; 472(1):255-61. PubMed ID: 26921446
[TBL] [Abstract][Full Text] [Related]
3. JAGGED1 expression is associated with prostate cancer metastasis and recurrence.
Santagata S; Demichelis F; Riva A; Varambally S; Hofer MD; Kutok JL; Kim R; Tang J; Montie JE; Chinnaiyan AM; Rubin MA; Aster JC
Cancer Res; 2004 Oct; 64(19):6854-7. PubMed ID: 15466172
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.
Terada N; Shiraishi T; Zeng Y; Aw-Yong KM; Mooney SM; Liu Z; Takahashi S; Luo J; Lupold SE; Kulkarni P; Getzenberg RH
J Cell Biochem; 2014 Sep; 115(9):1505-15. PubMed ID: 24604720
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.
Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH
J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
[TBL] [Abstract][Full Text] [Related]
7. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
[TBL] [Abstract][Full Text] [Related]
8. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
10. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of androgen receptors by NaAsO
Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS
Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958
[TBL] [Abstract][Full Text] [Related]
12. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682
[TBL] [Abstract][Full Text] [Related]
13. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells.
Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F
Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1.
Kim EJ; Kim SO; Jin X; Ham SW; Kim J; Park JB; Lee JY; Kim SC; Kim H
Tumour Biol; 2015 Apr; 36(4):2921-8. PubMed ID: 25514871
[TBL] [Abstract][Full Text] [Related]
15. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
Liu L; Dong X
PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
[TBL] [Abstract][Full Text] [Related]
16. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
18. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action.
Hu J; Zhu X; Lu Q
J Int Med Res; 2013 Aug; 41(4):1017-26. PubMed ID: 23839278
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells.
Lindqvist J; Imanishi SY; Torvaldson E; Malinen M; Remes M; Örn F; Palvimo JJ; Eriksson JE
Mol Biol Cell; 2015 Jun; 26(11):1971-84. PubMed ID: 25851605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]